Anti-TNFR1 targeting in humanized mice ameliorates disease in a model of multiple sclerosis.
Williams SK, Fairless R, Maier O, Liermann PC, Pichi K, Fischer R, Eisel ULM, Kontermann R, Herrmann A, Weksler B, Romero N, Couraud PO, Pfizenmaier K, Diem R.
Williams SK, et al. Among authors: liermann pc.
Sci Rep. 2018 Sep 11;8(1):13628. doi: 10.1038/s41598-018-31957-7.
Sci Rep. 2018.
PMID: 30206422
Free PMC article.